- Home
- Na Flow Cytometry Market
NA Flow Cytometry Market - Industry Trends and Forecast to 2029
- Published Date: September, 2022 | Report ID: CLS-552 | No of pages: 223 | Format:
The North America flow cytometry market is projected to register a substantial CAGR of 12.5% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.
Market Segmentation:
North America Flow Cytometry Market, By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry, and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales), Country (U.S., Canada, Mexico), Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of North America flow cytometry are:
Increase prevalence of chronic diseases
Rising geriatric population
Market Players:
Some of the major players operating in the North America flow cytometry market are:
Thermo Fisher Scientific Inc.
BD
Agilent Technologies, Inc.
Luminex Corporation (now subsidiary of DiaSorin S.p.A.)
Nexcelom Bioscience LLC
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Miltenyi Biotec
II-VI Incorporated
Beckman Coulter, Inc. (A subsidiary of Danaher Corporation)
Cytek Biosciences
bioMrieux SA
Q2 Solutions (a Subsidiary of IQVIA)
Cytonome/ST, LLC
Merck KGaA
Sony Biotechnology Inc.
Cell Signaling Technology, Inc.
NanoCellect Biomedical
Apogee Flow Systems Ltd.
Bay bioscience Co., Ltd.
Stratedigm, Inc
BioLegend, Inc.
NeoGenomics Laboratories
Enzo Biochem Inc.
Union Biometrica, Inc.
BennuBio Inc.
ORLFO Technologies
Elabscience Biotechnology Inc.
Takara Bio Inc.
TABLE OF CONTENT
TABLE OF CONTENTS
1 INTRODUCTION 38
1.1 OBJECTIVES OF THE STUDY 38
1.2 MARKET DEFINITION 38
1.3 OVERVIEW OF THE NORTH AMERICA FLOW CYTOMETRY MARKET 38
1.4 LIMITATIONS 40
1.5 MARKETS COVERED 41
2 MARKET SEGMENTATION 44
2.1 MARKETS COVERED 44
2.2 GEOGRAPHICAL SCOPE 45
2.3 YEARS CONSIDERED FOR THE STUDY 46
2.4 CURRENCY AND PRICING 46
2.5 DBMR TRIPOD DATA VALIDATION MODEL 47
2.6 MULTIVARIATE MODELLING 50
2.7 PRODUCT SEGMENT LIFELINE CURVE 50
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 51
2.9 DBMR MARKET POSITION GRID 52
2.10 MARKET APPLICATION COVERAGE GRID 53
2.11 VENDOR SHARE ANALYSIS 54
2.12 SECONDARY SOURCES 55
2.13 ASSUMPTIONS 55
3 EXECUTIVE SUMMARY 56
4 PREMIUM INSIGHTS 60
4.1 PORTERS FIVE FORCES 61
5 MARKET OVERVIEW 62
5.1 DRIVERS 64
5.1.1 RISING PREVALENCE OF CHRONIC DISEASES 64
5.1.2 INCREASING APPLICATION OF CYTOMETRY INSTRUMENTS 65
5.1.3 INCREASE IN USE OF FLOW CYTOMETRY IN DRUG DISCOVERY 66
5.1.4 GROWTH IN STEM CELL RESEARCH AND ACQUISITION OF RECOMBINATION OF DNA TECHNOLOGIES 67
5.2 RESTRAINTS 67
5.2.1 HIGH COST OF FLOW CYTOMETRY INSTRUMENTS 67
5.2.2 LIMITATIONS OF FLOW CYTOMETRY 68
5.2.3 LACK OF SKILLED PROFESSIONALS 69
5.3 OPPORTUNITIES 69
5.3.1 INCREASE IN ADOPTION OF FLOW CYTOMETRY TECHNIQUES IN RESEARCH AND ACADEMIA 69
5.3.2 DEVELOPMENT IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES 70
5.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 71
5.3.4 DEVELOPING PIPELINE OF STEM CELL RESEARCH 71
5.4 CHALLENGES 72
5.4.1 DIFFICULTY IN DEVELOPMENT AND VALIDATION OF FLOW CYTOMETRY ASSAYS 72
5.4.2 COMPLEXITIES RELATED TO REAGENT DEVELOPMENT 72
6 NORTH AMERICA FLOW CYTOMETRY MARKET, BY PRODUCT 74
6.1 OVERVIEW 75
6.2 REAGENTS AND CONSUMABLES 78
6.2.1 DYE 79
6.2.2 ANTIBODIES 79
6.2.3 BEADS 79
6.2.4 OTHERS 79
6.3 FLOW CYTOMETRY INSTRUMENTS 79
6.3.1 CELL ANALYZERS 81
6.3.1.1 CELL ANALYZERS, BY TYPE 81
6.3.1.1.1 IMAGING FLOW CYTOMETERS 81
6.3.1.1.2 NON-IMAGING FLOW CYTOMETERS 81
6.3.1.2 CELL ANALYZERS, BY MODALITY 81
6.3.1.2.1 BENCHTOP 82
6.3.1.2.2 STANDALONE 82
6.3.2 CELL SORTERS 82
6.3.2.1 BENCHTOP 82
6.3.2.2 STANDALONE 82
6.4 ACCESSORIES 82
6.4.1 FILTERS 84
6.4.2 DETECTORS 84
6.4.3 OTHERS 84
6.5 SERVICES 84
6.6 SOFTWARE 85
7 NORTH AMERICA FLOW CYTOMETRY MARKET, BY TECHNOLOGY 86
7.1 OVERVIEW 87
7.2 CELL-BASED FLOW CYTOMETRY 90
7.3 BEAD-BASED FLOW CYTOMETRY 90
8 NORTH AMERICA FLOW CYTOMETRY MARKET, BY APPLICATION 92
8.1 OVERVIEW 93
8.2 RESEARCH APPLICATIONS 96
8.2.1 CELL CYCLE ANALYSIS 97
8.2.2 CELL SORTING/SCREENING 97
8.2.3 CELL TRANSFECTION/VIABILITY 97
8.2.4 PHARMACEUTICAL AND BIOTECHNOLOGY 98
8.2.4.1 DRUG DISCOVERY 98
8.2.4.2 STEM CELL RESEARCH 98
8.2.4.3 IN VITRO TOXICITY TESTING 98
8.2.5 IMMUNOLOGY 98
8.2.6 APOPTOSIS 98
8.2.7 CELL COUNTING 98
8.2.8 OTHERS 98
8.3 CLINICAL APPLICATIONS 99
8.3.1 HAEMATOLOGY 100
8.3.2 CANCER 100
8.3.3 IMMUNODEFICIENCY DISEASES 100
8.3.4 ORGAN TRANSPLANTATION 100
8.3.5 OTHER CLINICAL APPLICATION 100
8.4 INDUSTRIAL APPLICATIONS 101
9 NORTH AMERICA FLOW CYTOMETRY MARKET, BY END USER 102
9.1 OVERVIEW 103
9.2 PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES 106
9.3 ACADEMIC & RESEARCH INSTITUTES 107
9.4 HOSPITALS 108
9.5 CLINICAL TESTING LABORATORIES 109
9.6 BLOOD BANK 110
9.7 OTHERS 111
10 NORTH AMERICA FLOW CYTOMETRY MARKET, BY DISTRIBUTION CHANNEL 112
10.1 OVERVIEW 113
10.2 RETAIL SALES 116
10.3 DIRECT TENDERS 117
11 NORTH AMERICA FLOW CYTOMETRY MARKET, BY REGION 118
11.1 NORTH AMERICA 119
11.1.1 U.S. 127
11.1.2 CANADA 131
11.1.3 MEXICO 135
12 NORTH AMERICA FLOW CYTOMETRY MARKET: COMPANY LANDSCAPE 139
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 139
13 SWOT ANALYSIS 140
14 COMPANY PROFILE 141
14.1 THERMO FISHER SCIENTIFIC INC. (2021) 141
14.1.1 COMPANY SNAPSHOT 141
14.1.2 REVENUE ANALYSIS 141
14.1.3 COMPANY SHARE ANALYSIS 142
14.1.4 PRODUCT PORTFOLIO 142
14.1.5 RECENT DEVELOPMENTS 143
14.1.5.1 ACQUISITION 143
14.2 BD (2021) 145
14.2.1 COMPANY SNAPSHOT 145
14.2.2 REVENUE ANALYSIS 145
14.2.3 COMPANY SHARE ANALYSIS 146
14.2.4 PRODUCT PORTFOLIO 146
14.2.5 RECENT DEVELOPMENT 147
14.2.5.1 COLLABORATION 147
14.3 AGILENT TECHNOLOGIES, INC. (2021) 148
14.3.1 COMPANY SNAPSHOT 148
14.3.2 REVENUE ANALYSIS 148
14.3.3 COMPANY SHARE ANALYSIS 149
14.3.4 PRODUCT PORTFOLIO 149
14.3.5 RECENT DEVELOPMENT 151
14.3.5.1 ACQUISITION 151
14.4 LUMINEX CORPORATION (NOW SUBSIDIARY OF DIASORIN S.P.A.) 152
14.4.1 COMPANY SNAPSHOT 152
14.4.2 COMPANY SHARE ANALYSIS 152
14.4.3 PRODUCT PORTFOLIO 153
14.4.4 RECENT DEVELOPMENTS 155
14.4.4.1 PRODUCT LAUNCH 155
14.5 SARTORIUS AG (2021) 156
14.5.1 COMPANY SNAPSHOT 156
14.5.2 REVENUE ANALYSIS 156
14.5.3 COMPANY SHARE ANALYSIS 157
14.5.4 PRODUCT PORTFOLIO 157
14.5.5 RECENT DEVELOPMENTS 158
14.6 BAY BIOSCIENCE CO., LTD. 159
14.6.1 COMPANY SNAPSHOT 159
14.6.2 PRODUCT PORTFOLIO 159
14.6.3 RECENT DEVELOPMENT 159
14.7 BIOMRIEUX SA (2021) 160
14.7.1 COMPANY SNAPSHOT 160
14.7.2 REVENUE ANALYSIS 160
14.7.3 PRODUCT PORTFOLIO 161
14.7.4 RECENT DEVELOPMENT 161
14.8 Q2 SOLUTION (A SUBSIDIARY OF IQVIA) 162
14.8.1 COMPANY SNAPSHOT 162
14.8.2 REVENUE ANALYSIS 162
14.8.3 SERVICE PORTFOLIO 163
14.8.4 RECENT DEVELOPMENT 163
14.9 TAKARA BIO INC. (2021) 164
14.9.1 COMPANY SNAPSHOT 164
14.9.2 REVENUE ANALYSIS 164
14.9.3 PRODUCT PORTFOLIO 165
14.9.4 RECENT DEVELOPMENTS 165
14.10 APOGEE FLOW SYSTEMS LTD. 166
14.10.1 COMPANY SNAPSHOT 166
14.10.2 PRODUCT PORTFOLIO 166
14.10.3 RECENT DEVELOPMENT 166
14.10.3.1 PRODUCT LAUNCH 166
14.11 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION) (2021) 167
14.11.1 COMPANY SNAPSHOT 167
14.11.2 REVENUE ANALYSIS 167
14.11.3 PRODUCT PORTFOLIO 168
14.11.4 RECENT DEVELOPMENTS 169
14.11.4.1 ACQUISITION 169
14.11.4.2 PRODUCT LAUNCH 170
14.12 BENNUBIO INC. 171
14.12.1 COMPANY SNAPSHOT 171
14.12.2 PRODUCT PORTFOLIO 171
14.12.3 RECENT DEVELOPMENTS 171
14.13 BIOLEGEND, INC. 172
14.13.1 COMPANY SNAPSHOT 172
14.13.2 PRODUCT PORTFOLIO 172
14.13.3 RECENT DEVELOPMENT 174
14.13.3.1 ACQUISITION 174
14.14 BIO-RAD LABORATORIES, INC. (2021) 176
14.14.1 COMPANY SNAPSHOT 176
14.14.2 REVENUE ANALYSIS 176
14.14.3 PRODUCT PORTFOLIO 177
14.14.4 RECENT DEVELOPMENT 177
14.15 CELL SIGNALING TECHNOLOGY, INC. 178
14.15.1 COMPANY SNAPSHOT 178
14.15.2 PRODUCT PORTFOLIO 178
14.15.3 RECENT DEVELOPMENT 179
14.16 CELLKRAFT BIOTECH PVT. LTD 180
14.16.1 COMPANY SNAPSHOT 180
14.16.2 PRODUCT PORTFOLIO 180
14.16.3 RECENT DEVELOPMENT 181
14.17 CYTEK BIOSCIENCES (2021) 182
14.17.1 COMPANY SNAPSHOT 182
14.17.2 PRODUCT PORTFOLIO 182
14.17.3 RECENT DEVELOPMENTS 183
14.17.3.1 PRODUCT LAUNCH 183
14.17.3.2 ACQUISITION 183
14.18 CYTOBUOY B.V. 185
14.18.1 COMPANY SNAPSHOT 185
14.18.2 PRODUCT PORTFOLIO 185
14.18.3 RECENT DEVELOPMENT 185
14.19 CYTONOME/ST, LLC 186
14.19.1 COMPANY SNAPSHOT 186
14.19.2 PRODUCT PORTFOLIO 186
14.19.3 RECENT DEVELOPMENTS 186
14.20 ELABSCIENCE BIOTECHNOLOGY INC. 187
14.20.1 COMPANY SNAPSHOT 187
14.20.2 PRODUCT PORTFOLIO 187
14.20.3 RECENT DEVELOPMENT 188
14.21 ENZO BIOCHEM INC. 189
14.21.1 COMPANY SNAPSHOT 189
14.21.2 REVENUE ANALYSIS 189
14.21.3 PRODUCT PORTFOLIO 190
14.21.4 RECENT DEVELOPMENTS 190
14.22 II-VI INCORPORATED (2021) 191
14.22.1 COMPANY SNAPSHOT 191
14.22.2 REVENUE ANALYSIS 191
14.22.3 PRODUCT PORTFOLIO 192
14.22.4 RECENT DEVELOPMENTS 192
14.22.4.1 PRODUCT LAUNCH 192
14.22.4.2 AWARDS 192
14.23 IKEDA SCIENTIFIC CO., LTD. 194
14.23.1 COMPANY SNAPSHOT 194
14.23.2 PRODUCT PORTFOLIO 194
14.23.3 RECENT DEVELOPMENT 195
14.24 MERCK KGAA (2021) 196
14.24.1 COMPANY SNAPSHOT 196
14.24.2 REVENUE ANALYSIS 196
14.24.3 PRODUCT PORTFOLIO 197
14.24.4 RECENT DEVELOPMENTS 197
14.24.4.1 COLLABORATION/ AGREEMENT 197
14.25 MILTENYI BIOTEC 199
14.25.1 COMPANY SNAPSHOT 199
14.25.2 PRODUCT PORTFOLIO 199
14.25.3 RECENT DEVELOPMENTS 200
14.25.3.1 PRODUCT LAUNCH 200
14.26 NANOCELLECT BIOMEDICAL 202
14.26.1 COMPANY SNAPSHOT 202
14.26.2 PRODUCT PORTFOLIO 202
14.26.3 RECENT DEVELOPMENTS 202
14.27 NEOGENOMICS LABORATORIES (2021) 204
14.27.1 COMPANY SNAPSHOT 204
14.27.2 REVENUE ANALYSIS 204
14.27.3 PRODUCT PORTFOLIO 205
14.27.4 RECENT DEVELOPMENT 205
14.28 NEXCELOM BIOSCIENCE LLC 206
14.28.1 COMPANY SNAPSHOT 206
14.28.2 PRODUCT PORTFOLIO 206
14.28.3 RECENT DEVELOPMENTS 206
14.29 ON-CHIP BIOTECHNOLOGIES CO., LTD. CORPORATION 208
14.29.1 COMPANY SNAPSHOT 208
14.29.2 PRODUCT PORTFOLIO 208
14.29.3 RECENT DEVELOPMENTS 208
14.30 ORFLO TECHNOLOGIES 209
14.30.1 COMPANY SNAPSHOT 209
14.30.2 PRODUCT PORTFOLIO 209
14.30.3 RECENT DEVELOPMENT 210
14.30.3.1 COLLABORATION 210
14.31 SONY BIOTECHNOLOGY INC. 211
14.31.1 COMPANY SNAPSHOT 211
14.31.2 PRODUCT PORTFOLIO 211
14.31.3 RECENT DEVELOPMENT 214
14.32 STRATEDIGM, INC 215
14.32.1 COMPANY SNAPSHOT 215
14.32.2 PRODUCT PORTFOLIO 215
14.32.3 RECENT DEVELOPMENTS 215
14.33 SYSMEX CORPORATION (2021) 216
14.33.1 COMPANY SNAPSHOT 216
14.33.2 REVENUE ANALYSIS 216
14.33.3 PRODUCT PORTFOLIO 217
14.33.4 RECENT DEVELOPMENT 217
14.33.4.1 ACQUISITION 217
14.34 UNION BIOMETRICA, INC. 218
14.34.1 COMPANY SNAPSHOT 218
14.34.2 PRODUCT PORTFOLIO 218
14.34.3 RECENT DEVELOPMENTS 218
15 QUESTIONNAIRE 220
16 RELATED REPORTS 223
Segmentation
Short Description
North America Flow Cytometry Market, By Product (Flow Cytometry Instruments, Reagents and Consumables, Software, Accessories, and Services), Technology (Cell-Based Flow Cytometry, and Bead-Based Flow Cytometry), Application (Research Applications, Clinical Applications, and Industrial Applications), End User (Academic & Research Institutes, Hospitals, Pharmaceutical & Biotechnology Companies, Clinical Testing Laboratories, Blood Bank, and Others), Distribution Channel (Direct Tenders, and Retail Sales), Country (U.S., Canada, Mexico), Industry Trends and Forecast to 2029
Market Definition:
Flow cytometry is a key process for screening cells from a heterologous cell mixture used in cell sorting, counting, protein regeneration, and engineering. The analysis of cell surface and intracellular molecule expression, the characterization and definition of various cell types in a heterogeneous cell population, the evaluation of the purity of isolated subpopulations, and the measurement of cell size and volume are all common uses for flow cytometry. It enables the simultaneous examination of multiple parameters for a single cell. A flow cytometer uses lasers to produce light, which is subsequently dispersed by the sample's cells, recorded by detectors, and converted into signals for analysis and measurement.
Most frequently used for analyzing peripheral blood, bone marrow, and other bodily fluids, flow cytometry offers a tried-and-true approach to identifying cells in solution. Flow cytometry studies are used to define hematological malignancies and identify and count immune cells. Fluorescent probes are used in flow cytometry to identify and describe cells or particles. Applications for flow cytometry include live/dead bacterial discrimination, membrane potential, immunophenotyping, transfection efficiency, apoptosis measurement, cell cycle analysis, fluorescent intensity, cell proliferation, cell sorting, and many more. Flow cytometry has a broad range of applications for research and clinical purposes, including cancer diagnosis, chromosome identification, and protein expression.
Flow cytometry is a technology that provides rapid multi-parametric analysis of single cells in solution. They utilize lasers as a light source and produce scattered and fluorescent light signals that get detected by detectors such as photodiodes or photomultiplier tubes attached to the cytometer.
Market Segmentation:
The North America flow cytometry market is categorized into five notable segments based on product, technology, application, end user, and distribution channel.
On the basis of product, the North America flow cytometry market is segmented into flow cytometry instruments, reagents and consumables, software, accessories, and services
On the basis of technology, the North America flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry
On the basis of application, the North America flow cytometry market is segmented into research applications, clinical applications, and industrial applications
On the basis of end user, the North America flow cytometry market is segmented into academic & research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others
On the basis of distribution channel, the North America flow cytometry market is segmented into direct tenders and retail sales
Market Players
Some of the major players operating in the North America flow cytometry market are:
Thermo Fisher Scientific Inc.
BD
Agilent Technologies, Inc.
Luminex Corporation (now subsidiary of DiaSorin S.p.A.)
Nexcelom Bioscience LLC
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Miltenyi Biotec
II-VI Incorporated
Beckman Coulter, Inc. (A subsidiary of Danaher Corporation)
Cytek Biosciences
bioMrieux SA
Q2 Solutions (a Subsidiary of IQVIA)
Cytonome/ST, LLC
Merck KGaA
Sony Biotechnology Inc.
Cell Signaling Technology, Inc.
NanoCellect Biomedical
Apogee Flow Systems Ltd.
Bay bioscience Co., Ltd.
Stratedigm, Inc
BioLegend, Inc.
NeoGenomics Laboratories
Enzo Biochem Inc.
Union Biometrica, Inc.
BennuBio Inc.
ORLFO Technologies
Elabscience Biotechnology Inc.
Takara Bio Inc.
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.